Fund shareholders of Fibrobiologics Inc
ISIN US31573L2043 · United States · LEI 5493000KQEGHXVWRMZ92
- Fund shareholders
- 4
- Of which ETFs
- 1 3 other funds
- Value held
- 97.8K $
- Share of capital
- 1.1 % of 6.7M shares on Jul 31, 2026
This issuer has other securities : FIBROBIOLOGICS INC (US31573L1052)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 39,897 | 52.7K $ | 0.60 % | as of Mar 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 27,769 | 36.7K $ | 0.42 % | as of Mar 31, 2026 ↗ | |
| iShares Micro-Cap ETF iShares Trust | 6,197 | 8.2K $ | 0.00 % | 0.09 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 254 | 335.3 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Micro-Cap ETF iShares Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.00 % | as of Mar 31, 2026 ↗ |
Institutional managers
13 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Fund Evaluation Group, LLC | 51,794 | 68.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 29,609 | 39.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 24,647 | 32.5K $ | as of Mar 31, 2026 |
| Cascade Financial Partners, LLC | 16,428 | 21.7K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 15,997 | 21.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 5,721 | 7.6K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 460 | 607 $ | as of Mar 31, 2026 |
| Western Wealth Management, LLC | 200 | 264 $ | as of Mar 31, 2026 |
| ISLAY CAPITAL MANAGEMENT, LLC | 169 | 223 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 154 | 203 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 66 | 87 $ | as of Mar 31, 2026 |
| Allworth Financial LP | 13 | 18 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 10 | 13 $ | as of Mar 31, 2026 |
Declared shareholders of Fibrobiologics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Lind Global Fund III LP and 2 others | 4.99 % | 230,234 | as of Apr 2, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Fibrobiologics Inc". https://titelia.com/en/stocks/fibrobiologics-inc-US31573L2043